Luca Unione

This paper synthesizes 6-sulfo sialyl Lewisx glycans to identify MERS-CoV's preferred receptor and develops a multivalent inhibitor.

This study identifies epistatic interactions in H3N2 influenza viruses that enable reversion to bind sialylated diLacNAc glycans, impacting receptor specificity and vaccine strain selection.

This paper identifies 9-O-acetylated sialic acids as a ligand for the SARS-CoV-2 NTD, revealing a dual-receptor functionality in the S1 domain that was rapidly selected against.